London: Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a deal worth up to USD 2 billion, the second sizeable acquisition it has announced…
Bengaluru: French drugmaker Sanofi said on Friday the European Medicines Agency has recommended the approval of a subcutaneous version of its blood cancer drug administered through an on-body injector.EMA's positive…
New Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary endpoints while further trials and regulatory pathways continue to…
New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Paroxetine Extended-Release Tablets USP, 12.5 mg, strengthening its portfolio in the…
New Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1 therapies for the treatment of type 2 diabetes…
Bengaluru: Biocon Limited today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee…
New Delhi: AAP MP Vikramjit Singh Sahney on Friday raised the issue of spurious medicines and expressed serious concern over the rising threat of substandard and counterfeit medicines in the…
New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail prices of 31 new drug formulations…
Mumbai: On Wednesday, the Bombay High Court pulled up the State Government over delays in resolving cases related to the deaths of children and mothers in the tribal region of…
As artificial intelligence tools become embedded in daily routines, concerns are rising over their psychological impact, especially among students preparing for competitive exams like NEET. A recent Reddit post highlighted…